English
简体中文
Total: £ 56.28
Published Date: 2026-04-01 | Pages: 176 | Tables: 172 | Medical Devices & Consumables
The global Pet In Vitro Diagnostics market was valued at US$ 4523 million in 2025 and is anticipated to reach US$ 7504 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Pet In Vitro Diagnostics refers to a combination of in vitro diagnostic products and technologies used to test pets (mainly companion animals such as dogs and cats). These products can detect and analyze pet blood, urine, saliva, and other biological samples to achieve disease diagnosis, health status assessment, and treatment effectiveness monitoring. These products include diagnostic kits, analytical instruments, molecular diagnostic systems, immunoassay devices, hematology and biochemical analyzers, etc., providing rapid, accurate, and repeatable test results for veterinary clinical decision-making. Pet IVD is an indispensable foundation of the pet healthcare system, helping to improve pet health management and disease control efficiency. The global Pet In Vitro Diagnostics (PET IVD) gross margin is projected to be around 30% by 2025.
In recent years, the pet IVD market has experienced unprecedented growth opportunities. The continued growth in the global pet population, increased awareness of pet healthcare, and rising demand for companion animal health management have driven the widespread adoption of diagnostic services. PET IVD products can rapidly and accurately test samples such as blood and urine, enabling veterinarians to identify pet diseases earlier, optimize treatment plans, and improve treatment efficiency. This trend is particularly evident in North America and Europe, while the Asia-Pacific and Latin America regions are also showing strong growth potential due to increased income and investment in pet healthcare. The rise of pet insurance, telemedicine, and rapid home testing tools has further expanded the application scenarios for Pet IVD. Despite the promising market prospects, the industry also faces challenges. First, pet IVD involves high technical barriers, especially the significant R&D investment and long product launch cycles required for high-precision molecular diagnostics and composite indicator detection systems. Second, the regulatory requirements for veterinary IVD products vary across countries, creating compliance pressures for international market expansion. Furthermore, price sensitivity, standardization of diagnostic result interpretation, and the complexity of integrating technologies such as AI-assisted analysis are all challenges that companies need to overcome. Intense competition in the low-to-mid-range rapid testing tool market may also squeeze the profit margins of some suppliers. Downstream demand is evolving from traditional clinical diagnostics to more comprehensive health management solutions. Rising demand in specific scenarios such as early screening for pet diseases, chronic disease monitoring, genotyping analysis, and drug response monitoring is driving the development of pet IVD products towards higher precision, multi-parameter capabilities, and intelligence. Particularly in pet hospitals, clinical laboratories, and pet healthcare service providers, the demand for molecular diagnostics, immunoassays, and automated analytical instruments is growing rapidly. Meanwhile, the convenience and data interconnectivity of home testing tools are also becoming new growth drivers.
This report delivers a comprehensive overview of the global Pet In Vitro Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pet In Vitro Diagnostics. The Pet In Vitro Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pet In Vitro Diagnostics market comprehensively. Regional market sizes by Type, by Application, by Animal, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pet In Vitro Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
IDEXX
Zoetis
Mars (Heska & Antech)
Median Diagnostics
Eurofins Ingenasa
Bio-Rad
Thermo Fisher Scientific
Randox
Innovative Diagnostics
Edan
Chengdu Seamaty Technology Co.,Ltd.
Digifluidic
Mindray Animal Medical
Guangzhou Wondfo Biotech Co.,Ltd.
Shenzhen Dymind Biotechnology Co., Ltd.
Ustar Biotechnologies
Genrui Biotech Inc.
Micropoint Biotechnologies,Co.,Ltd.
MNCHIP
Quicking Biotech Co., Ltd.
Coyote Bioscience Co.Ltd
Boehringer Ingelheim
GZMED
Sansure Biotech Inc.
URIT Medical Electronic Co., Ltd
Prokan
TECOM
Alovet Co., Ltd.
Segment by Type
Equipment
Reagents
Others
Segment by Animal
Dogs
Cats
Others (Rodents, Birds)
Segment by Technology
Immunoassay
Molecular Diagnostics
Hematology
Biochemistry Analysis
Others
Segment by Application
Pet Hospital
Household
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Animal, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pet In Vitro Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet In Vitro Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment
1.2.3 Reagents
1.2.4 Others
1.3 Market by Animal
1.3.1 Global Pet In Vitro Diagnostics Market Size Growth Rate by Animal: 2021 vs 2025 vs 2032
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others (Rodents, Birds)
1.4 Market by Technology
1.4.1 Global Pet In Vitro Diagnostics Market Size Growth Rate by Technology: 2021 vs 2025 vs 2032
1.4.2 Immunoassay
1.4.3 Molecular Diagnostics
1.4.4 Hematology
1.4.5 Biochemistry Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pet In Vitro Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pet Hospital
1.5.3 Household
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Pet In Vitro Diagnostics Market Perspective (2021–2032)
2.2 Global Pet In Vitro Diagnostics Growth Trends by Region
2.2.1 Global Pet In Vitro Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pet In Vitro Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Pet In Vitro Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Pet In Vitro Diagnostics Market Dynamics
2.3.1 Pet In Vitro Diagnostics Industry Trends
2.3.2 Pet In Vitro Diagnostics Market Drivers
2.3.3 Pet In Vitro Diagnostics Market Challenges
2.3.4 Pet In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Pet In Vitro Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Pet In Vitro Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Pet In Vitro Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pet In Vitro Diagnostics Revenue
3.4 Global Pet In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Pet In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet In Vitro Diagnostics Revenue in 2025
3.5 Global Key Players of Pet In Vitro Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Pet In Vitro Diagnostics, Products and Applications
3.7 Global Key Players of Pet In Vitro Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pet In Vitro Diagnostics Breakdown Data by Type
4.1 Global Pet In Vitro Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Pet In Vitro Diagnostics Forecasted Market Size by Type (2027–2032)
5 Pet In Vitro Diagnostics Breakdown Data by Application
5.1 Global Pet In Vitro Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Pet In Vitro Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pet In Vitro Diagnostics Market Size (2021–2032)
6.2 North America Pet In Vitro Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pet In Vitro Diagnostics Market Size by Country (2021–2026)
6.4 North America Pet In Vitro Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet In Vitro Diagnostics Market Size (2021–2032)
7.2 Europe Pet In Vitro Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pet In Vitro Diagnostics Market Size by Country (2021–2026)
7.4 Europe Pet In Vitro Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pet In Vitro Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Pet In Vitro Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pet In Vitro Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Pet In Vitro Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pet In Vitro Diagnostics Market Size (2021–2032)
9.2 Latin America Pet In Vitro Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pet In Vitro Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Pet In Vitro Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet In Vitro Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Pet In Vitro Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pet In Vitro Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Pet In Vitro Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IDEXX
11.1.1 IDEXX Company Details
11.1.2 IDEXX Business Overview
11.1.3 IDEXX Pet In Vitro Diagnostics Introduction
11.1.4 IDEXX Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.1.5 IDEXX Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Details
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Pet In Vitro Diagnostics Introduction
11.2.4 Zoetis Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.2.5 Zoetis Recent Development
11.3 Mars (Heska & Antech)
11.3.1 Mars (Heska & Antech) Company Details
11.3.2 Mars (Heska & Antech) Business Overview
11.3.3 Mars (Heska & Antech) Pet In Vitro Diagnostics Introduction
11.3.4 Mars (Heska & Antech) Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.3.5 Mars (Heska & Antech) Recent Development
11.4 Median Diagnostics
11.4.1 Median Diagnostics Company Details
11.4.2 Median Diagnostics Business Overview
11.4.3 Median Diagnostics Pet In Vitro Diagnostics Introduction
11.4.4 Median Diagnostics Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.4.5 Median Diagnostics Recent Development
11.5 Eurofins Ingenasa
11.5.1 Eurofins Ingenasa Company Details
11.5.2 Eurofins Ingenasa Business Overview
11.5.3 Eurofins Ingenasa Pet In Vitro Diagnostics Introduction
11.5.4 Eurofins Ingenasa Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.5.5 Eurofins Ingenasa Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Details
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Pet In Vitro Diagnostics Introduction
11.6.4 Bio-Rad Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.6.5 Bio-Rad Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Pet In Vitro Diagnostics Introduction
11.7.4 Thermo Fisher Scientific Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Randox
11.8.1 Randox Company Details
11.8.2 Randox Business Overview
11.8.3 Randox Pet In Vitro Diagnostics Introduction
11.8.4 Randox Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.8.5 Randox Recent Development
11.9 Innovative Diagnostics
11.9.1 Innovative Diagnostics Company Details
11.9.2 Innovative Diagnostics Business Overview
11.9.3 Innovative Diagnostics Pet In Vitro Diagnostics Introduction
11.9.4 Innovative Diagnostics Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.9.5 Innovative Diagnostics Recent Development
11.10 Edan
11.10.1 Edan Company Details
11.10.2 Edan Business Overview
11.10.3 Edan Pet In Vitro Diagnostics Introduction
11.10.4 Edan Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.10.5 Edan Recent Development
11.11 Chengdu Seamaty Technology Co.,Ltd.
11.11.1 Chengdu Seamaty Technology Co.,Ltd. Company Details
11.11.2 Chengdu Seamaty Technology Co.,Ltd. Business Overview
11.11.3 Chengdu Seamaty Technology Co.,Ltd. Pet In Vitro Diagnostics Introduction
11.11.4 Chengdu Seamaty Technology Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.11.5 Chengdu Seamaty Technology Co.,Ltd. Recent Development
11.12 Digifluidic
11.12.1 Digifluidic Company Details
11.12.2 Digifluidic Business Overview
11.12.3 Digifluidic Pet In Vitro Diagnostics Introduction
11.12.4 Digifluidic Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.12.5 Digifluidic Recent Development
11.13 Mindray Animal Medical
11.13.1 Mindray Animal Medical Company Details
11.13.2 Mindray Animal Medical Business Overview
11.13.3 Mindray Animal Medical Pet In Vitro Diagnostics Introduction
11.13.4 Mindray Animal Medical Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.13.5 Mindray Animal Medical Recent Development
11.14 Guangzhou Wondfo Biotech Co.,Ltd.
11.14.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Details
11.14.2 Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
11.14.3 Guangzhou Wondfo Biotech Co.,Ltd. Pet In Vitro Diagnostics Introduction
11.14.4 Guangzhou Wondfo Biotech Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.14.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
11.15 Shenzhen Dymind Biotechnology Co., Ltd.
11.15.1 Shenzhen Dymind Biotechnology Co., Ltd. Company Details
11.15.2 Shenzhen Dymind Biotechnology Co., Ltd. Business Overview
11.15.3 Shenzhen Dymind Biotechnology Co., Ltd. Pet In Vitro Diagnostics Introduction
11.15.4 Shenzhen Dymind Biotechnology Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.15.5 Shenzhen Dymind Biotechnology Co., Ltd. Recent Development
11.16 Ustar Biotechnologies
11.16.1 Ustar Biotechnologies Company Details
11.16.2 Ustar Biotechnologies Business Overview
11.16.3 Ustar Biotechnologies Pet In Vitro Diagnostics Introduction
11.16.4 Ustar Biotechnologies Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.16.5 Ustar Biotechnologies Recent Development
11.17 Genrui Biotech Inc.
11.17.1 Genrui Biotech Inc. Company Details
11.17.2 Genrui Biotech Inc. Business Overview
11.17.3 Genrui Biotech Inc. Pet In Vitro Diagnostics Introduction
11.17.4 Genrui Biotech Inc. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.17.5 Genrui Biotech Inc. Recent Development
11.18 Micropoint Biotechnologies,Co.,Ltd.
11.18.1 Micropoint Biotechnologies,Co.,Ltd. Company Details
11.18.2 Micropoint Biotechnologies,Co.,Ltd. Business Overview
11.18.3 Micropoint Biotechnologies,Co.,Ltd. Pet In Vitro Diagnostics Introduction
11.18.4 Micropoint Biotechnologies,Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.18.5 Micropoint Biotechnologies,Co.,Ltd. Recent Development
11.19 MNCHIP
11.19.1 MNCHIP Company Details
11.19.2 MNCHIP Business Overview
11.19.3 MNCHIP Pet In Vitro Diagnostics Introduction
11.19.4 MNCHIP Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.19.5 MNCHIP Recent Development
11.20 Quicking Biotech Co., Ltd.
11.20.1 Quicking Biotech Co., Ltd. Company Details
11.20.2 Quicking Biotech Co., Ltd. Business Overview
11.20.3 Quicking Biotech Co., Ltd. Pet In Vitro Diagnostics Introduction
11.20.4 Quicking Biotech Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.20.5 Quicking Biotech Co., Ltd. Recent Development
11.21 Coyote Bioscience Co.Ltd
11.21.1 Coyote Bioscience Co.Ltd Company Details
11.21.2 Coyote Bioscience Co.Ltd Business Overview
11.21.3 Coyote Bioscience Co.Ltd Pet In Vitro Diagnostics Introduction
11.21.4 Coyote Bioscience Co.Ltd Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.21.5 Coyote Bioscience Co.Ltd Recent Development
11.22 Boehringer Ingelheim
11.22.1 Boehringer Ingelheim Company Details
11.22.2 Boehringer Ingelheim Business Overview
11.22.3 Boehringer Ingelheim Pet In Vitro Diagnostics Introduction
11.22.4 Boehringer Ingelheim Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.22.5 Boehringer Ingelheim Recent Development
11.23 GZMED
11.23.1 GZMED Company Details
11.23.2 GZMED Business Overview
11.23.3 GZMED Pet In Vitro Diagnostics Introduction
11.23.4 GZMED Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.23.5 GZMED Recent Development
11.24 Sansure Biotech Inc.
11.24.1 Sansure Biotech Inc. Company Details
11.24.2 Sansure Biotech Inc. Business Overview
11.24.3 Sansure Biotech Inc. Pet In Vitro Diagnostics Introduction
11.24.4 Sansure Biotech Inc. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.24.5 Sansure Biotech Inc. Recent Development
11.25 URIT Medical Electronic Co., Ltd
11.25.1 URIT Medical Electronic Co., Ltd Company Details
11.25.2 URIT Medical Electronic Co., Ltd Business Overview
11.25.3 URIT Medical Electronic Co., Ltd Pet In Vitro Diagnostics Introduction
11.25.4 URIT Medical Electronic Co., Ltd Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.25.5 URIT Medical Electronic Co., Ltd Recent Development
11.26 Prokan
11.26.1 Prokan Company Details
11.26.2 Prokan Business Overview
11.26.3 Prokan Pet In Vitro Diagnostics Introduction
11.26.4 Prokan Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.26.5 Prokan Recent Development
11.27 TECOM
11.27.1 TECOM Company Details
11.27.2 TECOM Business Overview
11.27.3 TECOM Pet In Vitro Diagnostics Introduction
11.27.4 TECOM Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.27.5 TECOM Recent Development
11.28 Alovet Co., Ltd.
11.28.1 Alovet Co., Ltd. Company Details
11.28.2 Alovet Co., Ltd. Business Overview
11.28.3 Alovet Co., Ltd. Pet In Vitro Diagnostics Introduction
11.28.4 Alovet Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (2021–2026)
11.28.5 Alovet Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pet In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Equipment
Table 3. Key Players of Reagents
Table 4. Key Players of Others
Table 5. Global Pet In Vitro Diagnostics Market Size Growth Rate by Animal (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Dogs
Table 7. Key Players of Cats
Table 8. Key Players of Others (Rodents, Birds)
Table 9. Global Pet In Vitro Diagnostics Market Size Growth Rate by Technology (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Immunoassay
Table 11. Key Players of Molecular Diagnostics
Table 12. Key Players of Hematology
Table 13. Key Players of Biochemistry Analysis
Table 14. Key Players of Others
Table 15. Global Pet In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Pet In Vitro Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pet In Vitro Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 18. Global Pet In Vitro Diagnostics Market Share by Region (2021–2026)
Table 19. Global Pet In Vitro Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 20. Global Pet In Vitro Diagnostics Market Share by Region (2027–2032)
Table 21. Pet In Vitro Diagnostics Market Trends
Table 22. Pet In Vitro Diagnostics Market Drivers
Table 23. Pet In Vitro Diagnostics Market Challenges
Table 24. Pet In Vitro Diagnostics Market Restraints
Table 25. Global Pet In Vitro Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 26. Global Pet In Vitro Diagnostics Market Share by Players (2021–2026)
Table 27. Global Top Pet In Vitro Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pet In Vitro Diagnostics Revenue, 2025
Table 28. Ranking of Global Top Pet In Vitro Diagnostics Companies by Revenue (US$ Million) in 2025
Table 29. Global 5 Largest Players Market Share by Pet In Vitro Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 30. Global Key Players of Pet In Vitro Diagnostics, Headquarters and Area Served
Table 31. Global Key Players of Pet In Vitro Diagnostics, Products and Applications
Table 32. Global Key Players of Pet In Vitro Diagnostics, Date of General Availability (GA)
Table 33. Mergers and Acquisitions, Expansion Plans
Table 34. Global Pet In Vitro Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 35. Global Pet In Vitro Diagnostics Revenue Market Share by Type (2021–2026)
Table 36. Global Pet In Vitro Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 37. Global Pet In Vitro Diagnostics Revenue Market Share by Type (2027–2032)
Table 38. Global Pet In Vitro Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 39. Global Pet In Vitro Diagnostics Revenue Market Share by Application (2021–2026)
Table 40. Global Pet In Vitro Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 41. Global Pet In Vitro Diagnostics Revenue Market Share by Application (2027–2032)
Table 42. North America Pet In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. North America Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 44. North America Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 45. Europe Pet In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Europe Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 47. Europe Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 48. Asia-Pacific Pet In Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 49. Asia-Pacific Pet In Vitro Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 50. Asia-Pacific Pet In Vitro Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 51. Latin America Pet In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Latin America Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 53. Latin America Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 54. Middle East & Africa Pet In Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Middle East & Africa Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 56. Middle East & Africa Pet In Vitro Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 57. IDEXX Company Details
Table 58. IDEXX Business Overview
Table 59. IDEXX Pet In Vitro Diagnostics Product
Table 60. IDEXX Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 61. IDEXX Recent Development
Table 62. Zoetis Company Details
Table 63. Zoetis Business Overview
Table 64. Zoetis Pet In Vitro Diagnostics Product
Table 65. Zoetis Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 66. Zoetis Recent Development
Table 67. Mars (Heska & Antech) Company Details
Table 68. Mars (Heska & Antech) Business Overview
Table 69. Mars (Heska & Antech) Pet In Vitro Diagnostics Product
Table 70. Mars (Heska & Antech) Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 71. Mars (Heska & Antech) Recent Development
Table 72. Median Diagnostics Company Details
Table 73. Median Diagnostics Business Overview
Table 74. Median Diagnostics Pet In Vitro Diagnostics Product
Table 75. Median Diagnostics Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 76. Median Diagnostics Recent Development
Table 77. Eurofins Ingenasa Company Details
Table 78. Eurofins Ingenasa Business Overview
Table 79. Eurofins Ingenasa Pet In Vitro Diagnostics Product
Table 80. Eurofins Ingenasa Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 81. Eurofins Ingenasa Recent Development
Table 82. Bio-Rad Company Details
Table 83. Bio-Rad Business Overview
Table 84. Bio-Rad Pet In Vitro Diagnostics Product
Table 85. Bio-Rad Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 86. Bio-Rad Recent Development
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Pet In Vitro Diagnostics Product
Table 90. Thermo Fisher Scientific Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Randox Company Details
Table 93. Randox Business Overview
Table 94. Randox Pet In Vitro Diagnostics Product
Table 95. Randox Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 96. Randox Recent Development
Table 97. Innovative Diagnostics Company Details
Table 98. Innovative Diagnostics Business Overview
Table 99. Innovative Diagnostics Pet In Vitro Diagnostics Product
Table 100. Innovative Diagnostics Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 101. Innovative Diagnostics Recent Development
Table 102. Edan Company Details
Table 103. Edan Business Overview
Table 104. Edan Pet In Vitro Diagnostics Product
Table 105. Edan Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 106. Edan Recent Development
Table 107. Chengdu Seamaty Technology Co.,Ltd. Company Details
Table 108. Chengdu Seamaty Technology Co.,Ltd. Business Overview
Table 109. Chengdu Seamaty Technology Co.,Ltd. Pet In Vitro Diagnostics Product
Table 110. Chengdu Seamaty Technology Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 111. Chengdu Seamaty Technology Co.,Ltd. Recent Development
Table 112. Digifluidic Company Details
Table 113. Digifluidic Business Overview
Table 114. Digifluidic Pet In Vitro Diagnostics Product
Table 115. Digifluidic Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 116. Digifluidic Recent Development
Table 117. Mindray Animal Medical Company Details
Table 118. Mindray Animal Medical Business Overview
Table 119. Mindray Animal Medical Pet In Vitro Diagnostics Product
Table 120. Mindray Animal Medical Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 121. Mindray Animal Medical Recent Development
Table 122. Guangzhou Wondfo Biotech Co.,Ltd. Company Details
Table 123. Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
Table 124. Guangzhou Wondfo Biotech Co.,Ltd. Pet In Vitro Diagnostics Product
Table 125. Guangzhou Wondfo Biotech Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 126. Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
Table 127. Shenzhen Dymind Biotechnology Co., Ltd. Company Details
Table 128. Shenzhen Dymind Biotechnology Co., Ltd. Business Overview
Table 129. Shenzhen Dymind Biotechnology Co., Ltd. Pet In Vitro Diagnostics Product
Table 130. Shenzhen Dymind Biotechnology Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 131. Shenzhen Dymind Biotechnology Co., Ltd. Recent Development
Table 132. Ustar Biotechnologies Company Details
Table 133. Ustar Biotechnologies Business Overview
Table 134. Ustar Biotechnologies Pet In Vitro Diagnostics Product
Table 135. Ustar Biotechnologies Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 136. Ustar Biotechnologies Recent Development
Table 137. Genrui Biotech Inc. Company Details
Table 138. Genrui Biotech Inc. Business Overview
Table 139. Genrui Biotech Inc. Pet In Vitro Diagnostics Product
Table 140. Genrui Biotech Inc. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 141. Genrui Biotech Inc. Recent Development
Table 142. Micropoint Biotechnologies,Co.,Ltd. Company Details
Table 143. Micropoint Biotechnologies,Co.,Ltd. Business Overview
Table 144. Micropoint Biotechnologies,Co.,Ltd. Pet In Vitro Diagnostics Product
Table 145. Micropoint Biotechnologies,Co.,Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 146. Micropoint Biotechnologies,Co.,Ltd. Recent Development
Table 147. MNCHIP Company Details
Table 148. MNCHIP Business Overview
Table 149. MNCHIP Pet In Vitro Diagnostics Product
Table 150. MNCHIP Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 151. MNCHIP Recent Development
Table 152. Quicking Biotech Co., Ltd. Company Details
Table 153. Quicking Biotech Co., Ltd. Business Overview
Table 154. Quicking Biotech Co., Ltd. Pet In Vitro Diagnostics Product
Table 155. Quicking Biotech Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 156. Quicking Biotech Co., Ltd. Recent Development
Table 157. Coyote Bioscience Co.Ltd Company Details
Table 158. Coyote Bioscience Co.Ltd Business Overview
Table 159. Coyote Bioscience Co.Ltd Pet In Vitro Diagnostics Product
Table 160. Coyote Bioscience Co.Ltd Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 161. Coyote Bioscience Co.Ltd Recent Development
Table 162. Boehringer Ingelheim Company Details
Table 163. Boehringer Ingelheim Business Overview
Table 164. Boehringer Ingelheim Pet In Vitro Diagnostics Product
Table 165. Boehringer Ingelheim Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 166. Boehringer Ingelheim Recent Development
Table 167. GZMED Company Details
Table 168. GZMED Business Overview
Table 169. GZMED Pet In Vitro Diagnostics Product
Table 170. GZMED Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 171. GZMED Recent Development
Table 172. Sansure Biotech Inc. Company Details
Table 173. Sansure Biotech Inc. Business Overview
Table 174. Sansure Biotech Inc. Pet In Vitro Diagnostics Product
Table 175. Sansure Biotech Inc. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 176. Sansure Biotech Inc. Recent Development
Table 177. URIT Medical Electronic Co., Ltd Company Details
Table 178. URIT Medical Electronic Co., Ltd Business Overview
Table 179. URIT Medical Electronic Co., Ltd Pet In Vitro Diagnostics Product
Table 180. URIT Medical Electronic Co., Ltd Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 181. URIT Medical Electronic Co., Ltd Recent Development
Table 182. Prokan Company Details
Table 183. Prokan Business Overview
Table 184. Prokan Pet In Vitro Diagnostics Product
Table 185. Prokan Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 186. Prokan Recent Development
Table 187. TECOM Company Details
Table 188. TECOM Business Overview
Table 189. TECOM Pet In Vitro Diagnostics Product
Table 190. TECOM Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 191. TECOM Recent Development
Table 192. Alovet Co., Ltd. Company Details
Table 193. Alovet Co., Ltd. Business Overview
Table 194. Alovet Co., Ltd. Pet In Vitro Diagnostics Product
Table 195. Alovet Co., Ltd. Revenue in Pet In Vitro Diagnostics Business (US$ Million), 2021–2026
Table 196. Alovet Co., Ltd. Recent Development
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
Table 200. Authors List of This Report
List of Figures
Figure 1. Pet In Vitro Diagnostics Picture
Figure 2. Global Pet In Vitro Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Pet In Vitro Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Equipment Features
Figure 5. Reagents Features
Figure 6. Others Features
Figure 7. Global Pet In Vitro Diagnostics Market Size Comparison by Animal (US$ Million), 2021–2032
Figure 8. Dogs Features
Figure 9. Cats Features
Figure 10. Others (Rodents, Birds) Features
Figure 11. Global Pet In Vitro Diagnostics Market Size Comparison by Technology (US$ Million), 2021–2032
Figure 12. Immunoassay Features
Figure 13. Molecular Diagnostics Features
Figure 14. Hematology Features
Figure 15. Biochemistry Analysis Features
Figure 16. Others Features
Figure 17. Global Pet In Vitro Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 18. Global Pet In Vitro Diagnostics Market Share by Application: 2025 vs 2032
Figure 19. Pet Hospital Case Studies
Figure 20. Household Case Studies
Figure 21. Other Case Studies
Figure 22. Pet In Vitro Diagnostics Report Years Considered
Figure 23. Global Pet In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global Pet In Vitro Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Pet In Vitro Diagnostics Market Share by Region: 2025 vs 2032
Figure 26. Global Pet In Vitro Diagnostics Market Share by Players in 2025
Figure 27. Global Pet In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Pet In Vitro Diagnostics Revenue in 2025
Figure 29. North America Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America Pet In Vitro Diagnostics Market Share by Country (2021–2032)
Figure 31. United States Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Pet In Vitro Diagnostics Market Share by Country (2021–2032)
Figure 35. Germany Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Pet In Vitro Diagnostics Market Share by Region (2021–2032)
Figure 43. China Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Pet In Vitro Diagnostics Market Share by Country (2021–2032)
Figure 51. Mexico Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Pet In Vitro Diagnostics Market Share by Country (2021–2032)
Figure 55. Israel Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE Pet In Vitro Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. IDEXX Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 59. Zoetis Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 60. Mars (Heska & Antech) Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 61. Median Diagnostics Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 62. Eurofins Ingenasa Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 63. Bio-Rad Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 65. Randox Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 66. Innovative Diagnostics Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 67. Edan Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 68. Chengdu Seamaty Technology Co.,Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 69. Digifluidic Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 70. Mindray Animal Medical Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 71. Guangzhou Wondfo Biotech Co.,Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 72. Shenzhen Dymind Biotechnology Co., Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 73. Ustar Biotechnologies Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 74. Genrui Biotech Inc. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 75. Micropoint Biotechnologies,Co.,Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 76. MNCHIP Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 77. Quicking Biotech Co., Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 78. Coyote Bioscience Co.Ltd Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 79. Boehringer Ingelheim Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 80. GZMED Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 81. Sansure Biotech Inc. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 82. URIT Medical Electronic Co., Ltd Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 83. Prokan Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 84. TECOM Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 85. Alovet Co., Ltd. Revenue Growth Rate in Pet In Vitro Diagnostics Business (2021–2026)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
